DB17959ExperimentalProtein Based Therapies
Human ciliary neurotrophic factor, recombinant was investigated for macular telangiectasia in two clinical trials. The trials were NCT03071965, an extension study of the NT-501 CNTF implant for macular telangiectasia, and...
- Also known as
- Ciliary neurotrophic factor, recombinant human
Resolves to
Compound
Which companies are running trials of Human ciliary neurotrophic factor, recombinant (E. coli), in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account